Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros statement on media inquiry concerning former Board member Schlieren (Zurich), Switzerland, September 18, 2025 - Kuros Bioscien ...
Photos, left by ECM photographers: La Mesa protest, riot and arson May 30-31, 2020. May 30, 2025 (La Mesa) – It’s been five years since the last Saturday in May 2020, when the city of La Mesa found ...
SMBC Group and Jefferies initially entered into a Strategic Alliance in 2021 to collaborate on future corporate and investment banking business opportunities. In 2023, the Alliance was expanded to ...
Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, has become aware of a possible imminent publication in a Dutch financial media outlet regarding the ...
Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial.
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
MatrixSeven / file-transfer-go Public Notifications You must be signed in to change notification settings Fork 396 Star 3.1k ...
MegaParse is a powerful and versatile parser that can handle various types of documents with ease. Whether you're dealing with text, PDFs, Powerpoint presentations, Word documents MegaParse has got ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback